Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cardiomyopathies

• EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy
• Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
• Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
• CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
• Polypill for Prevention of Cardiomyopathy
• Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
• An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
• A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
• A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
• Therapy to Maintain Remission in Dilated Cardiomyopathy
• Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
• Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
• A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
• Effect of Dapagliflozin on Secondary Mitral Regurgitation
• Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
• Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
• Sympathetic and Vascular Function in Takotsubo Syndrome
• The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
• A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of NAN-101 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Fa
• A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
• LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
• Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Efficacy of Trimetazidine in Diabetic Patients
• Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
• Venous Ethanol for Ventricular Tachycardia
• A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis
• A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
• Examining the Effects of Mitochondrial Oxidative Stress in DCM
• Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy
• Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
• Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
• Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
• Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
• Micophenolate Mofetil Versus Azathioprine in Myocarditis
• SGLT2 Inhibitors in ATTR
• CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM
• Empagliflozin in Hypertrophic Cardiomyopathy
• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
• Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
• A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM
• Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects
• Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
• The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD
• Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
• Clinical Study of ATTR-CM
• Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
• Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
• Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
• New Horizons for the Treatment of Cardiomyopathy in Children
• Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia
• Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.
• CY 6022 is an Open Label Study to Collect Long-term Safety and Tolerability Data for CK-3773274
• ION-682884 in Patients With TTR Amyloid Cardiomyopathy
• A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
• A Study to Evaluate the Effect of IMB-1018972 on Cardiac Energetics in Patients With Type 2 Diabetes (IMPROVE-DiCE)
• A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
• Safety, Tolerability and Pharmacokinetics Study of CK-3773274
• The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
• Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
• A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
• The DAPA-MEMRI Trial
• Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants
• A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
• Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy
• Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
• Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)
• Role of Perhexiline in Hypertrophic Cardiomyopathy
• A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
• Early Administration of Ivabradine in Children With Heart Failure
• First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
• A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
• Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?
• Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial
• REDWOOD-HCM: Randomized Evaluation of Dosing With CK-3773274 in Obstructive Outflow Disease in HCM
• The Effects of SGLTi on Diabetic Cardiomyopathy
• The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
• AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR)Trial
• Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
• Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
• Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
• HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
• Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
• Ivabradine in Cirrhotic Cardiomyopathy
• Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
• Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
• Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
• Taurine in Peripartum Cardiomyopathy
• TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
• Randomized Evaluation and Verification of Ventricular Enhancement
• Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
• Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
• Bisoprolol in DMD Early Cardiomyopathy
• Simvastatin Therapy in Patients With Dilated Cardiomyopathy.
• A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
• A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
• 24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients
• Pilot Randomized Trial With Flecainide in ARVC Patients
• Open-Label Study of AG10 in Patients With Cardiomyopathy
• The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.
• Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
• Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER
• Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Study of AG10 in Amyloid Cardiomyopathy
• Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
• A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
• A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
• Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
• Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging
• Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.
• Spironolactone Therapy in Chronic Stable Right HF Trial
• Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
• Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10
• Nitrite in Hypertrophic Cardiomyopathy (HCM) Study
• Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
• Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)
• Contrast ICE for Myocardial Scar in VT Ablations
• A Trial Testing Amiodarone in Chagas Cardiomiopathy
• Peripartum Cardiomyopathy in Nigeria Registry
• A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
• Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
• Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
• Pulse Reduction On Beta-blocker and Ivabradine Therapy
• Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
• Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
• Risk Stratification of Heart Failure in Cardiomyopathies.
• Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury
• Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
• Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease
• Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome
• Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
• A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
• Withdrawal of Medication in Recovered DCM
• Pilot - Peri-operative Beta Blockade
• Adenosine as an Adjunct to Blood Cardioplegia
• Mobilization of Endothelial Progenitor Cells and Aspirin
• An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
• Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
• Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
• AiDing Diuresis wIth Tolvaptan (ADD-IT)
• Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock
• Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy
• Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
• Hypertrophic Cardiomyopathy Symptom Release by BX1514M
• Bromocriptine in the Treatment of Peripartum Cardiomyopathy
• Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
• Fatty Acid Oxidation Defects and Insulin Sensitivity
• Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
• HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)
• Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)
• Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
• Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines
• Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
• A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
• Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
• ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
• Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
• Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
• Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
• Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients
• Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy
• A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
• Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
• 18F-deoxyglucose (FDG) PET-CMD
• Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population
• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
• A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
• Spironolactone Against Anthracycline-induced Cardiomyopathy
• Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
• Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
• Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease
• Cardiomyopathy in DMD: Lisinopril vs. Losartan
• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
• Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
• Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure
• Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
• Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
• Identification of Carnitine-Responsive Cardiomyopathy
• CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
• 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System
• Effect of Metoprolol on Thalassemia Cardiomyopathy
• PHOspholamban RElated CArdiomyopathy STudy - Intervention
• Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
• Impact of Ranolazine on Coronary Microcirculatory Resistance
• REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
• Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
• Study of the Acute Effects of Triheptanoin in Heart Failure
• A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)
• Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
• Ranolazine for the Treatment of Chest Pain in HCM Patients
• The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
• Trimetazidine Therapy in Hypertrophic Cardiomyopathy
• Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
• Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers
• Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
• Vitamin D3 Supplementation for Heart Failure Patients
• PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
• A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
• Hypertrophic Regression With N-Acetylcysteine in HCM
• Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
• Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy
• Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy
• Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
• Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
• Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy
• Use of Beta-agonists in Stable Severe Congestive Heart Failure
• Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG
• Pilot Study of COR-1 in Heart Failure
• Ranolazine in Ischemic Cardiomyopathy
• B-type Natriuretic Peptide and Glucose Metabolism
• A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure
• Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
• Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
• Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
• PUFAs and Left Ventricular Function in Heart Failure
• Ranolazine Implantable Cardioverter-Defibrillator Trial
• Spanish Atrial Fibrillation And Resynchronization Study
• Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
• The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study
• Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
• The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
• Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
• Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
• Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy
• Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
• Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
• Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy
• Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy
• Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
• Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
• The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
• Nesiritide - Dilated Cardiomyopathy
• Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
• The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy
• The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
• PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
• IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load
• Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
• Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
• Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
• The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy
• Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
• Effect of Aldosterone on Energy Starvation in Heart Failure
• Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
• Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department
• Effect of Rosuvastatin on Left Ventricular Remodeling
• Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy
• Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
• CHANCE - Candesartan in Hypertrophic Cardiomyopathy
• CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
• Therapy With Verapamil or Carvedilol in Chronic Heart Failure
• Cell Therapy in Chagas Cardiomyopathy
• Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy
• Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity
• Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
• Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart
• Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
• A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy
• Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
• Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
• DOCICAR: Cardiac Dysfunction in Cirrhosis
• Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics
• Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy
• Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
• Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
• Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
• Pirfenidone to Treat Hypertrophic Cardiomyopathy
• Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
• Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
• Enalapril After Anthracycline Cardiotoxicity